title: [Urapidil and dopamine in severe heart failure. A clinical case].
abstract: The Authors report their experience with a new vasodilator drug (Urapidil) employed in the management of serious cardiac failure, in a patient who previously didn't respond in a satisfactory manner to a therapy with Dopamine alone. After several days of continuous treatment, the patient was discharged, without any sign of toxic or metabolic reactions.
authors.affiliation: Rianimazione, Ospedale Civile di Mondovì, Cuneo.
authors.forename: E
authors.initials: E
authors.lastname: Balla
authors.forename: L
authors.initials: L
authors.lastname: Fenoglio
authors.forename: E
authors.initials: E
authors.lastname: Ravera
authors.forename: D
authors.initials: D
authors.lastname: Bono
mesh_terms: D000368:Aged; D004298:Dopamine / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D010879:Piperazines; D014665:Vasodilator Agents; C015568:urapidil; D004298:Dopamine
vernacular_title: Urapidil e dopamina nello scompenso cardiaco grave. Caso clinico.